ACTRN12624000960550尚未招募2 期
ASAPP: Efficacy of Azithromycin for Short cervix and Amniotic fluid sludge for the Prevention of Preterm birth, a pilot randomised controlled trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Pregnant women from 13 weeks 0 days gestation to 24 weeks 0 days gestation, with cervical length less than or equal to 25.0mm, sonographic appearance of amniotic fluid sludge and absence of symptoms suggestive of labour at randomisation.
排除标准
- •Multiple gestation, major or lethal fetal congenital abnormality, placenta praevia/vasa praevia, PPROM, clinical signs suggestive of chorioamnionitis, indicated preterm delivery at time of randomisation, known allergy to Azithromycin, use of medications likely to prolong QT interval, history of cardiac disease, known hepatic impairment.
研究者
相似试验
已完成
4 期
Azithromycin for the treatment of pelvic inflammatory disease (PID)Topic: Infection, Reproductive Health and ChildbSubtopic: Infection (all Subtopics), Reproductive Health and Childb (all Subtopics)Disease: Infectious diseases and microbiology , Reproductive Health & ChildbirthUrological and Genital DiseasesInflammatory diseases of female pelvic organsISRCTN51790058Brighton and Sussex University Hospitals NHS Trust (UK)313
进行中（未招募）
不适用
Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)? - Azithromycin for the treatment of PIDPelvic Inflammatory Disease (PID)MedDRA version: 14.1Level: PTClassification code 10034254Term: Pelvic inflammatory diseaseSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-023254-36-GBBrighton and Sussex University Hospitals NHS Trust
已完成
不适用
Comparison effect of Azithromycin and Amoxiclave in treatment of acute sinusitis.Sinusitis.Diseases of respiratory systemIRCT201401046252N5Shahrekord University of Medical Sciences78
招募中
3 期
Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19COVID-19.Covid-19U07.1IRCT20080901001165N50Sina Darou Laboratories Company80
招募中
不适用
Efficacy and safety of azithromycin infusion in patients with NHCAP categorized as group B according to the JRS Guidelines for the Management of Nursing and Healthcare-Associated Pneumonia in Adultsursing and Healthcare-Associated PneumoniaJPRN-UMIN000014677Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan60